000			01558nam a22005055i 4500
001			978-3-0346-0094-1
003			DE-He213
005			20130515021211.0
007			cr nn 008mamaa
008			110105s2011 sz | s |||| 0|eng d
020			_a9783034600941 _9978-3-0346-0094-1
024	7		_a10.1007/978-3-0346-0094-1 _2doi
050		4	_aRM1-950
072		7	_aMMG _2bicssc
072		7	_aMED071000 _2bisacsh
082	0	4	_a615 _223
100	1		_aSibilia, Maria.
245	1	0	_aDrugs for HER-2-positive Breast Cancer _h[electronic resource] / _cedited by Maria Sibilia, Christoph C. Zielinski, Rupert Bartsch, Thomas W. Grunt.
260			_aBasel : _bSpringer Basel, _c2011.
300			_bdigital.
490	0		_aMilestones in Drug Therapy
650		0	_aMedicine.
650		0	_aOncology.
650		0	_aImmunology.
650		0	_aMonoclonal antibodies.
650		0	_aToxicology.
650		0	_aInternal medicine.
650	1	4	_aBiomedicine.
650	2	4	_aPharmacology/Toxicology.
650	2	4	_aOncology.
650	2	4	_aCancer Research.
650	2	4	_aAntibodies.
650	2	4	_aImmunology.
650	2	4	_aInternal Medicine.
700	1		_aZielinski, Christoph C.
700	1		_aBartsch, Rupert.
700	1		_aGrunt, Thomas W.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783034600934
830		0	_aMilestones in Drug Therapy
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-0346-0094-1
912			_aZDB-2-SBL
999			_c74967 _d74967